Invention Grant
US08852874B2 Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro
有权
抗淀粉样蛋白 静脉注射免疫球蛋白（IVIG）体外活性
- Patent Title: Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro
- Patent Title (中): 抗淀粉样蛋白 静脉注射免疫球蛋白（IVIG）体外活性
-
Application No.: US12392267Application Date: 2009-02-25
-
Publication No.: US08852874B2Publication Date: 2014-10-07
- Inventor: Katarzyna Olas , Birgit Reipert , Hans-Peter Schwarz , Hartmut Ehrlich
- Applicant: Katarzyna Olas , Birgit Reipert , Hans-Peter Schwarz , Hartmut Ehrlich
- Applicant Address: US IL Deerfield CH Glattpark (Opfikon)
- Assignee: Baxter International Inc.,Baxter Healthcare SA
- Current Assignee: Baxter International Inc.,Baxter Healthcare SA
- Current Assignee Address: US IL Deerfield CH Glattpark (Opfikon)
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: G01N33/68
- IPC: G01N33/68 ; G01N33/50 ; C12Q1/32 ; A61K39/395
Abstract:
The present invention relates to a cell-based in vitro screening assay for identifying and selecting therapeutic agents that inhibit amyloid β-induced cytotoxicity.
Public/Granted literature
- US20090221017A1 ANTI-AMYLOID BETA ACTIVITY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN VITRO Public/Granted day:2009-09-03
Information query
IPC分类:
